Medical Cannabis in Greece

Recommendation
12/13 November 2025
How to implement EU-GMP Chapter 8
Greece is currently discussing a new bill about medical cannabis products. The proposal is entitled: Production, Export and Distribution of final medical cannabis products made from Cannabis Sativa L. with a Tetrahydrocannabinol (THC) content of more than 0,2%.
Greece legalized medical cannabis in 2017, and repealed a ban on cultivation and production in March 2018. However, growers and producers must set up a Greek company to buy or lease land, prepare the documentation for the installation license and then apply for an operations license and a medical license from the National Organization for Medicines to begin cultivation and / or production.
Exported products will be solely subject to the laws and regulations in the country importing them
The purpose of the proposal is to allow medical cannabis companies in Greece, to produce medical cannabis and export it to Europe. According to the proposal, the medical cannabis would not be subject to the same laws as that sold domestically, which must follow the existing legislation calling for approval by the Hellenic Organization of Pharmaceuticals. Exported products will be solely subject to the laws, regulations and GMP/GDP guidelines in the country importing them.
For more information please visit the portal of the Hellenic parliament.
Related GMP News
02.04.2025BfArM Guideline for the Application for a Licence to Cultivate Cannabis
27.03.2025Can RWD support Medical Cannabis Evalution?
27.03.2025Omission of the German Cannabis Monograph
04.03.2025FDA requests Information on the Use of Cannabis Products in Animals
04.03.2025How to Classify Borderline Products?
30.01.2025FDA seeks Feedback on Opiate Alkaloid Content of Poppy Seeds